Noramco
Noramco
Noramco
  • About Us
    • About Noramco
    • Our People
    • Leadership
    • Excellence in Compliance
    • Minimizing Risk
  • Products & Solutions
    • Active Pharmaceutical Ingredients
      • Active Pharmaceutical Ingredients
      • Nal Family of Antagonists
      • ADHD / Stimulants
      • Full Product List
    • Noramco Solutions
      • Noramco Solutions
      • Clinical Supply
      • Controlled Substance Building Blocks and Intermediates
    • Platform Technologies
      • Platform Technologies
      • Platform Technology: Custom Synthesis
    • Reference Standards
      • Reference Standards
      • Reference Standards: Custom Synthesis
    • Reference Standards Store
  • Careers
  • News & Events
    • News & Events
    • Press Releases
  • Contact

Sort by

  • Default sorting
  • Sort by popularity
  • Sort by newness
  • Sort by price: low to high
  • Sort by price: high to low

View

  • 9 items
  • 15 items
  • 30 items

Showing 10–18 of 23 results

  • 78_Dihydrothebainone-Base
    Quick ViewSelect options

    Dihydrothebainone Base (CII)

    $288.00 – $1,152.00
    <span style="color: #000000;"><strong>OTHER NAMES:</strong></span> USP Compound A <span style="color: #000000;"><strong>CAS#</strong></span> 847-86-9 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0911-**
    Quick ViewSelect options
  • 79_Hydrocodone-Aldol-Dimer
    Quick ViewSelect options

    Hydrocodone Aldol Dimer (CII)

    $4,750.00 – $19,000.00
    <span style="color: #000000;"><strong>NDC#</strong></span> 51634-2170-**
    Quick ViewSelect options
  • 80_Hydrocodone-Base
    Quick ViewSelect options

    Hydrocodone Base (CII)

    $232.00 – $1,160.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 125-29-1 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0015-**
    Quick ViewSelect options
  • 81_Hydrocodone-Bitartrate
    Quick ViewSelect options

    Hydrocodone Bitartrate (CII)

    $232.00 – $1,160.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 34195-34-1 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0104-**
    Quick ViewSelect options
  • 82_Hydrocodone-N-Oxide
    Quick ViewSelect options

    Hydrocodone N-Oxide (CII)

    $1,150.00 – $4,600.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 909265-05-0 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-1000-**
    Quick ViewSelect options
  • 83_Hydromorphone-Hydrochloride
    Quick ViewSelect options

    Hydromorphone Hydrochloride (CII)

    $173.00 – $3,460.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 71-68-1 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0057-**
    Quick ViewSelect options
  • 84_Methylene-Bridged-Hydromorphone-Dimer-Base
    Quick ViewSelect options

    Methylene Bridged Hydromorphone Dimer Base (CII)

    $863.00 – $3,452.00
    <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0933-**
    Quick ViewSelect options
  • 85_Methylene-Bridged-Morphine-Dimer-Base
    Quick ViewSelect options

    Methylene Bridged Morphine Dimer Base (CII)

    $863.00 – $3,452.00
    <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0932-**
    Quick ViewSelect options
  • 65_Morphine-Base
    Quick ViewSelect options

    Morphine Base (CII)

    $575.00 – $2,875.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 57-27-2 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0018-**
    Quick ViewSelect options
  • 1
  • 2
  • 3

Recent Articles

  • Noramco CEO Lee Karras discusses $25 million Halo investment with PharmTech
  • Diversifying the Supply of Raw Materials
  • Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider
  • Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
  • Noramco Announces Submission and Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide
Copyright 2025 Noramco. All Rights Reserved. Contact | Legal Notice | Privacy Policy | Terms & Conditions | Benefits Transparency Mandate